- Pioglitazone - (https://medlineplus.gov/druginfo/meds/a699016.html#:)
- Implications of Removing Rosiglitazone’s Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426122/#:)
- Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes - (https://clinicaltrials.gov/ct2/show/NCT01156597)
- A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control - (https://pubmed.ncbi.nlm.nih.gov/16914074/#:)
- Pioglitazone - (https://www.ncbi.nlm.nih.gov/books/NBK548327/#:)
Pioglitazone (Pioglaz (30mg)) is a thiazolidinedione antidiabetic, prescribed for type 2 diabetes in certain patients. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines. It lowers blood sugar by reducing insulin resistance.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Pioglaz (30mg) - East West Pharmaceuticals Pvt. Ltd.
Pioglaz (30mg) Tablet
Generic : Pioglitazone
Substitute/Alternative Medication to Pioglaz (30mg)
When is Pioglaz (30mg) prescribed?
It is prescribed for -